Larimar Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
LRMR on Nasdaq
Location
Three Bala Plaza East. Suite 506, Bala Cynwyd, PA

Insiders trading volume in the past year

Larimar Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James E. Flynn Director, * Director by Deputization, 10%+ Owner $186M +$37.5M +25.3% May 29, 2024
Deerfield Partners, L.P. Director, Dir. by Deputization/10% Group, 10%+ Owner $10.4M Sep 16, 2022
Thomas Edward Hamilton Director $6.33M +$500K +8.58% Feb 16, 2024
Maimon Carole Ben President and CEO, Director $1.24M Jan 17, 2024
Michael Celano Chief Financial Officer $537K Jan 17, 2024
Gopi Shankar Chief Development Officer $103K +$18.7K +22.2% Jan 17, 2024
Russell Clayton Chief Medical Officer $84K Jan 17, 2024
Frank E. Thomas Director $22K +$22K May 29, 2024
Thomas O. Daniel Director May 12, 2021
Jonathan Leff Director May 29, 2024
Jeffrey W. Sherman Director May 29, 2024
Joseph Truitt Director May 29, 2024
Peter Barrett Director May 10, 2022

Recent Insider Transactions by Companies or Individuals for Larimar Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.